During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year (QALY) from various perspectives. During this podcast, we sit down with 2 of the panelists to continue the QALY discussion.
During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year from various perspectives.
During this podcast, we sit down with Jennifer Bright, MPA, the executive director of the Innovation and Value Initiative, who moderated the discussion, and Lou Garrison, PhD, assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, who participated in the discussion.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen